United States · FDA National Drug Code directory
Roflumilast
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1674_eb40db9e-ddc1-4041-aac5-ff0f2c478fc6
- Product NDC
- 70771-1674
- Form
- TABLET
- Composition / generic term
- Roflumilast
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221003
- Source listing expiry
- 20261231
Source-listed ingredients
- ROFLUMILAST — 500 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (70771-1674-3) · 70771-1674-3
- 90 TABLET in 1 BOTTLE (70771-1674-9) · 70771-1674-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →